Hympavzi

Active Ingredient(s): Marstacimab-hncq
FDA Approved: * October 11, 2024
Pharm Company: * PFIZER INC
Category: Blood Clotting (Hemostasis)
* May have multiple approval dates, manufacturers, or labelers.